Meeting the needs of the older patient through advanced product development and design

Sponsored by: Capsugel

Focused on:

  • Drug
  • Therapy
  • Product
  • Development

Date: 2 March


Time: 3PM London/4PM Paris/10AM New York

Addressing the needs and trends of an ageing patient

Drug product development is traditionally being done on a single compound in patients with a single disease or at least strictly randomized and surveyed. This often misses the "real patients" and major user group to which 70 % in volume of our drugs are prescribed to - the patients beyond 65 years.

There is a lot of misperception on this particular patient profile, and even less has been done in scientific research to understand this demographic and its needs. As a major contributor to achieve the therapeutic outcomes, the concerned patient plays an important role - creating a significant opportunity for pharmaceutical companies who are investing in age appropriate product development and design.

This webinar will focus on two major areas in the development of age appropriate products:

1. The specific physiological derived needs of older adults
2. Common Issue with medication and dosage form recommendation for older adults

The objective is to draw a basic picture on the real older patients and their needs in complex drug therapy and discuss how this translates into advanced product development and design.

Presented by

Sven Stegemann, PhD,

Professor for Patient Centric Drug Development and Manufacturing, Graz University of Technology

Sven Stegemann has been the Director for Pharmaceutical Business Development at Capsugel since 1997, the world leader in capsules and capsule technologies. In September 2014 he joined the Graz University of Technology in Austria as a Professor for Patient Centric Drug Product Design and Manufacturing.

Sven Stegemann is a pharmacist by training and holds a PhD in pharmacology. He started his career at Sanofi-Aventis working in different roles of the pharmaceutical product development and manufacturing cycle. Before joining Capsugel he worked for Asta Medica where he was responsible for product licensing. In his position at the Graz University of Technology he will focus his scientific research on the rational development of patient centric drug products and their manufacturing technologies as well as education and training of students and young scientists.

Frédérique Bordes-Picard,

Business Development Manager EMEA, Capsugel

Frédérique Bordes-Picard has been working in the Pharmaceutical Industry for more than 15 years, mainly in Pharmaceutical Development and Formulation.

Since joining Capsugel as Business Development Manager back in 2010, she has been providing support to many pharmaceutical companies for the development of capsule-based formulations including innovative products, generics and OTC.

Key Learning Objectives

  • Older patient needs and age related changes
  • Pharmacotherapy in older adults
  • Common issues and problems with medication use in older adults
  • Considerations for dosage form development


  • Heads of Research and Development
  • Heads of Formulation
  • Business Development
  • Product Management
  • Brand Managers
  • R&D Scientists
  • Scientists
  • CEOs
  • General Managers
  • Formulation Scientists